Panic Disorder: Symptoms, Brain Science and Treatment

What Is Panic Disorder?

Panic disorder is an anxiety condition characterised by recurrent, unexpected panic attacks. Each attack typically peaks within 10 minutes and is accompanied by intense physical symptoms and overwhelming fear. The entire episode usually resolves on its own within 20 to 30 minutes.

The lifetime prevalence is approximately 2% to 5% worldwide, with women affected two to three times more often than men^[1]. Onset most commonly occurs in early adulthood (between the ages of 20 and 30), though it can appear at any age. Many patients initially present to emergency departments or cardiologists to rule out heart disease before being referred to a psychiatrist.

This page is a concise condition overview. For a more detailed discussion, including differential diagnosis from generalised anxiety and cardiac conditions, as well as self-help techniques during an attack, please see the comprehensive panic disorder guide (Chinese).

Causes and Brain Mechanisms

Panic disorder is not overthinking or nervousness. Research clearly shows structural and functional abnormalities in the brain's fear circuitry of panic disorder patients.

The Fear Circuit and Key Brain Regions

The neuroanatomical model proposed by Gorman and colleagues in 2000 remains the most influential framework for understanding panic disorder^[2]. At its core, the amygdala is hypersensitive to threat signals, triggering a full fight-or-flight response even in the absence of actual danger. This produces the cascade of autonomic symptoms that define a panic attack.

Brain Regions and Neurotransmitters Implicated in Panic Disorder

Neurotransmitters

Serotonin is the principal pharmacological target. SSRIs modulate amygdala sensitivity and lower the baseline activation level of the fear circuit^[1].

Norepinephrine, released in large quantities by the locus coeruleus, drives the classic panic symptoms of palpitations, trembling, and sweating. SNRIs (serotonin-norepinephrine reuptake inhibitors) act on both systems simultaneously, which is why they can be particularly effective for some patients.

GABA (gamma-aminobutyric acid) is the brain's primary inhibitory neurotransmitter. Studies have found reduced cortical GABA concentrations in panic disorder patients^[2], which explains why benzodiazepines (which enhance GABA activity) can rapidly relieve acute attacks.

Genetics and Environment

Having a first-degree relative with panic disorder raises one's own risk by roughly four to eight times. Twin studies estimate the heritability at approximately 30% to 40%^[1]. Environmental factors matter equally: major life stressors, childhood adversity, and excessive caffeine intake are common triggers.

Common Symptoms

During a panic attack, at least 4 of the 13 core symptoms listed in the DSM-5 are present. The most frequently reported include:

• Palpitations or rapid heartbeat
• Sweating, trembling
• Shortness of breath or a feeling of choking
• Chest pain or discomfort
• Dizziness or unsteadiness
• Numbness or tingling in the hands and feet
• Derealisation (the surroundings feel unreal)
• Fear of losing control or fear of dying

Attacks typically peak within 10 minutes and subside within 30 minutes. A panic attack itself is not fatal. However, the anticipatory anxiety that follows ("When will the next one strike?") and the avoidance behaviours that develop in response are what progressively erode quality of life.

Treatment

Medication

First-line pharmacotherapy consists of SSRIs or SNRIs. International guidelines recommend a treatment duration of at least 6 to 12 months^[3]. Commonly prescribed options include:

• Sertraline
• Escitalopram
• Paroxetine
• Venlafaxine

These medications require 4 to 6 weeks to reach full effect. They are not addictive, but should not be stopped abruptly without medical guidance.

Benzodiazepines (BZDs) can be used during acute attacks, offering rapid relief within approximately 30 minutes. However, they carry risks of tolerance and dependence and are used only as short-term bridging agents. Common examples include Alprazolam and Clonazepam. In my practice, every BZD prescription specifies the circumstances of use and is paired with regular follow-up to assess whether tapering is possible.

Psychotherapy

Cognitive behavioural therapy (CBT) is the most evidence-supported psychotherapy for panic disorder^[4]. Panic-specific CBT incorporates two core techniques:

• Cognitive restructuring: identifying catastrophic thoughts such as "my racing heart must mean a heart attack" and learning to interpret body signals more accurately
• Interoceptive exposure: deliberately inducing physical sensations similar to those in a panic attack (for example, hyperventilating or spinning in a chair) so the body can repeatedly experience these sensations in a safe setting, gradually reducing the fear response

Meta-analyses show that a full 12-week course of CBT is comparable to medication in efficacy, with lower relapse rates after treatment ends^[4]. For patients who prefer not to take long-term medication, or who are planning a pregnancy, CBT is an especially worthwhile consideration.

Another less common but preliminarily supported approach is panic-focused psychodynamic therapy, which may suit patients who do not adapt well to the cognitive-behavioural framework.

rTMS (Repetitive Transcranial Magnetic Stimulation)

The evidence for rTMS in panic disorder is not yet as robust as it is for depression or OCD. A small number of studies suggest that high-frequency stimulation of the prefrontal cortex may help reduce anticipatory anxiety, but no large randomised controlled trials have confirmed efficacy. This remains an active area of research and is not currently included in standard panic disorder treatment guidelines.

Self-Screening

The GAD-7 (Generalised Anxiety Disorder scale) can serve as a preliminary anxiety severity screen. If your score falls in the moderate or above range, or if you have begun avoiding certain situations out of fear of an attack, scheduling a psychiatric appointment is recommended.

Go to online self-assessment tools

When to Seek Help

If any of the following apply to you, please do not wait:

• Attacks are becoming more frequent, from occasional to once a week or more
• You have started avoiding driving, taking lifts, or going to crowded places
• Worry about the next attack is affecting your work or relationships
• You have begun using alcohol or sleeping pills to suppress the discomfort
• Your mood has declined due to repeated attacks, with signs of depression emerging

Panic disorder is highly treatable. International studies show that over 70% of patients who receive regular treatment achieve remission or experience only minimal residual symptoms within six months.

References

1. Roy-Byrne PP, Craske MG, Stein MB. Panic disorder. Lancet. 2006;368(9540):1023-1032. DOI PubMed
2. Gorman JM, Kent JM, Sullivan GM, Coplan JD. Neuroanatomical hypothesis of panic disorder, revised. Am J Psychiatry. 2000;157(4):493-505. DOI PubMed
3. National Institute for Health and Care Excellence (NICE). Generalised anxiety disorder and panic disorder in adults: management. Clinical guideline CG113. London: NICE; 2011 (updated 2020). NICE
4. Hofmann SG, Smits JAJ. Cognitive-behavioral therapy for adult anxiety disorders: a meta-analysis of randomized placebo-controlled trials. J Clin Psychiatry. 2008;69(4):621-632. DOI PubMed
5. Craske MG, Stein MB. Anxiety. Lancet. 2016;388(10063):3048-3059. DOI PubMed